Literature DB >> 18365968

Cardiac surgery in patients on chronic hemodialysis: short and long-term survival.

A Kogan1, B Medalion, R Kornowski, E Raanani, E Sharoni, A Stamler, G Sahar, E Snir, E Porat.   

Abstract

OBJECTIVE: Open-heart surgery carries a high risk for hemodialysis patients. This study focuses on the short and long-term outcomes of hemodialysis patients undergoing heart surgery.
DESIGN: The study was carried out as a retrospective analysis in the Department of Cardiothoracic Surgery in a large university-affiliated hospital. PATIENTS: 115 hemodialysis patients underwent cardiac surgery in our department between 1 July 1996 and 31 July 2006. 67.5 % (77 patients) underwent isolated coronary artery bypass grafting (CABG), 13.2 % (15 patients) underwent isolated aortic valve replacement (AVR) and 20.2 % (23 patients) underwent mitral valve surgery or combined valve and coronary artery bypass grafting or multiple valve surgery.
METHODS: The relationship between several variables (age, sex, hypertension, diabetes, and previous myocardial infarction, type of disease, preoperative ejection fraction, and congestive heart failure) and operative (30 days) mortality and late survival was analyzed.
RESULTS: The overall 30-day mortality was 18.3 % (21 patients). It was 13 % (10/77 patients) for the isolated CABG group and 13.3 % (2/15) for the isolated AVR group. Patients undergoing combined valve and coronary surgery or multiple valve surgery had a higher perioperative mortality of 39.1 % (9/23) compared to the isolated CABG and isolated AVR patients. Perioperative death was also higher in patients with moderate and severe LV dysfunction, and in patients with diabetes. The duration of dialysis periods was not related to perioperative death. Mean follow-up was 26.4 +/- 29.7 months (0.1 to 104 months). Actuarial survival at 1 year and 5 years was 76 % and 55 % for isolated CABG, 59 % and 21 % for isolated AVR, and 44 % and 33 % for all other cases, respectively (log rank P = 0.001).
CONCLUSION: Patients on dialysis have a high risk of perioperative mortality and poor long-term survival rates. Mortality is higher and survival is worse after combined CABG and valve-related procedures or multiple valve surgery than after isolated CABG and AVR.

Entities:  

Mesh:

Year:  2008        PMID: 18365968     DOI: 10.1055/s-2007-989396

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  5 in total

1.  Heart surgery in patients on chronic dialysis: is there still room for improvement in early and long-term outcome?

Authors:  Francesco Nicolini; Claudio Fragnito; Alberto Molardi; Andrea Agostinelli; Riccardo Campodonico; Igino Spaggiari; Cesare Beghi; Tiziano Gherli
Journal:  Heart Vessels       Date:  2010-10-15       Impact factor: 2.037

Review 2.  Outcomes following cardiac surgery in patients with preoperative renal dialysis.

Authors:  Hunaid A Vohra; Lesley A Armstrong; Amit Modi; Clifford W Barlow
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-09-20

3.  Comparing cardiac surgery in peritoneal dialysis and hemodialysis patients: perioperative outcomes and two-year survival.

Authors:  Victoria A Kumar; Shubha Ananthakrishnan; Scott A Rasgon; Eric Yan; Raoul Burchette; Karen Dewar
Journal:  Perit Dial Int       Date:  2011-09-30       Impact factor: 1.756

4.  Long term hemodialysis aggravates lipolytic activity reduction and very low density, low density lipoproteins composition in chronic renal failure patients.

Authors:  Khedidja Mekki; Josiane Prost; Mustapha Remaoun; Jacques Belleville; Malika Bouchenak
Journal:  BMC Cardiovasc Disord       Date:  2009-08-26       Impact factor: 2.298

Review 5.  Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease.

Authors:  Navdeep K Bhatti; Keyvan Karimi Galougahi; Yehuda Paz; Tamim Nazif; Jeffrey W Moses; Martin B Leon; Gregg W Stone; Ajay J Kirtane; Dimitri Karmpaliotis; Sabahat Bokhari; Mark A Hardy; Geoffrey Dube; Sumit Mohan; Lloyd E Ratner; David J Cohen; Ziad A Ali
Journal:  J Am Heart Assoc       Date:  2016-08-04       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.